Aigen Investment Management LP Acquires New Position in Agilent Technologies, Inc. (NYSE:A)

Aigen Investment Management LP purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 2,247 shares of the medical research company's stock, valued at approximately $302,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Flynn Zito Capital Management LLC lifted its position in shares of Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock valued at $251,000 after acquiring an additional 69 shares during the period. IFP Advisors Inc lifted its position in shares of Agilent Technologies by 17.7% during the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock valued at $62,000 after acquiring an additional 69 shares during the period. Brown Brothers Harriman & Co. lifted its position in shares of Agilent Technologies by 13.5% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company's stock valued at $96,000 after acquiring an additional 77 shares during the period. Rothschild Investment LLC lifted its position in shares of Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock valued at $66,000 after acquiring an additional 79 shares during the period. Finally, Rovin Capital UT ADV lifted its position in shares of Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company's stock valued at $750,000 after acquiring an additional 81 shares during the period.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the business's stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. Citigroup raised their price objective on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research note on Thursday, December 19th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research note on Monday, December 9th. StockNews.com raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. JPMorgan Chase & Co. dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Tuesday, November 26th. Finally, Bank of America dropped their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research note on Friday, December 13th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $146.15.

Remove Ads

Agilent Technologies Stock Up 0.0 %

A stock opened at $126.59 on Friday. The stock has a market capitalization of $36.09 billion, a P/E ratio of 29.10, a PEG ratio of 3.55 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a one year low of $121.45 and a one year high of $155.35. The company has a 50 day moving average price of $139.67 and a two-hundred day moving average price of $138.69.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.78%. Agilent Technologies's dividend payout ratio is presently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.